xRead - September 2022

Wise et al.

Page 321

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Study Year LOE Study design Study groups Clinical endpoint Conclusion

Chng et al. 746 2004 3b Cross-sectional School children (n = 11,114) Questionnaire Snoring in 34%, AR associated with snoring (OR 2.9; 95% CI, 2.06–4.08).

Anuntaseree et al. 747 2001 3b Cross-sectional Randomly selected children (n = 1,142) PSG, questionnaire Prevalence habitual snoring 8.5%, OSAS 0.69%; OR 5.27 in children with AR. Bhattacharjee et al. 748 2010 4 Prognostic cohort Children undergoing AT for OSA (n = 578) PSG AR identified in 39% of children with OSA undergoing AT. Goldbart et al. 749 2005 4 Case series SDB (n = 24) PSG, lateral neck X ray

Montelukast treatment for 16 weeks decreased adenoid size and respiratory sleep disturbances. Kidon et al. 750 2004 4 Case series Children with AR undergoing SPT (n = 202) History 17% of AR patients reported HS. Mansfield et al. 751 2004 4 Case series Children with AR (n = 14) PSG, RQLQ Treating AR decreases AHI. McColley et al. 752 1997 4 Case series Children with HS (n = 39) PSG Positive skin test associated with OSA.

AHI = apnea-hypopnea index; AR = allergic rhinitis; AT = adenotonsillectomy; CCAAPS = Cincinnati Allergy and Air Pollution Study; CI =confidence interval; HS =habitual snoring; LOE = level of evidence; NAR = non-allergic rhinitis; OR = odds ratio; OSA = obstructive sleep apnea; OSA-18 = 18-item quality-of-life survey for obstructive sleep apnea; OSAS = obstructive sleep apnea syndrome; PSG = polysomnogram; QOL = quality of life; REM = rapid eye movement; RQLQ = Rhinoconjunctivitis Quality of Life Questionnaire; SDB = sleep disordered breathing; SPT = skin prick test; T&A = tonsillectomy and adenoidectomy.

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.